NPR Notícias de negócios: A Look At How The Revolving Door Spins From FDA To Industry

A Look At How The Revolving Door Spins From FDA To Industry
About 27 percent of Food and Drug Administration reviewers who approved hematology-oncology drugs from 2001 through 2010 left to work for the industry they previously regulated, an analysis found.

leia mais em NPR